Community-acquired methicillin-resistant Staphylococcus aureus in a returned traveler

Infectious Diseases in Clinical Practice

Volumn 13, Issue 3, 2005, Pages 139-141

  Shrestha, Rabin K ^a,c   Padmanabhan, Ravindran A ^a   Saravolatz, Louis D ^b   Hall, Geraldine S ^a   Gordon, Steven M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^c L4 Microbiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; TETRACYCLINE; VANCOMYCIN;

AGED; ARTICLE; BLOOD CULTURE; CASE REPORT; CELLULITIS; CLINICAL FEATURE; CONGO; DEBRIDEMENT; DEEP VEIN THROMBOSIS; ECHOCARDIOGRAPHY; ERYTHEMA; HUMAN; HYDROTHERAPY; LEG SWELLING; LYMPHADENOPATHY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SKIN INFECTION; TRAVEL; WOUND CARE;

EID: 18544386086     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000161513.56749.89     Document Type: Article

References (13)

1. Kain KC. Skin lesions in returned travelers. Med Clin North Am. 1999;83(4):1077-1102.
2. Centers for Disease Control. Community-acquired methicillin-resistant Staphylococcus aureus infections - Michigan. MMWR Morb Mortal Wkly Rep. 1981;30(16):185-187.
3. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279(8):593-598.
4. Purcell K, Fergie JE. Exponential increase in community-acquired methicillin-resistant Staphylococcus aureus infections in South Texas children. Pediatr Infect Dis J. 2002;21(10):988-989.
5. Hiramatsu K, Okuma K, Ma XX, et al. New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community. Curr Opin Infect Dis. 2002;15(4):407-413.
6. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants - Colorado, Indiana, Pennsylvania, and Los Angeles county, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52(33):793-795.
7. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis. 2003;16(2):103-124.
8. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis. 2003;9(8):978-984.
9. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36(2):131-139.
10. Udo EE, Grubb WB. Genetic analysis of methicillin-resistant Staphylococcus aureus from a Nigerian hospital. J Med Microbiol. 1993;38(3):203-208.
11. Ikeh EI. Methicillin resistant Staphylococcus aureus (MRSA) at JOS University teaching hospital. Afr J Clin Exp Microbiol. 2003;4(1):52-55.
12. Mason PR, Kitai I, Chigonde S. Community acquired staphylococcal skin infections in rural areas of Zimbabwe. Cent Afr J Med. 1991;37(2):56-60.
13. Liassine N, Auckenthaler R, Descombes M, et al. Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol. 2004;42(2):825-828.